The acidic intrinsically disordered region of the inflammatory mediator HMGB1 mediates fuzzy interactions with chemokine CXCL12
M. V. Mantonico, F. De Leo, G. Quilici, L. Colley, F. De Marchis, M. Crippa, T. Schulte, C. Zucchelli, S. Ricagno, G. Giachin, m. ghitti, M. E. Bianchi, G. Musco
Abstract
Chemokines engage in heterodimeric interactions to activate or dampen their cognate receptors in inflammatory conditions. The chemokine CXCL12 forms with the alarmin HMGB1 a patho-physiologically relevant heterocomplex (HMGB1[bullet]CXCL12), whose formation synergically promotes the inflammatory response elicited by the G-protein coupled receptor CXCR4. However, the molecular details of complex formation were still elusive. Through an integrative structural approach (NMR, AUC, ITC, MST, SAXS) we show that HMGB1[bullet]CXCL12 represents the first fuzzy chemokines heterocomplex reported so far. HMGB1 and CXCL12 form a dynamic equimolar assembly, rather than involving one HMGB1 and two CXCL12 molecules as previously assumed, with structured and unstructured HMGB1 regions recognizing the dimerization surface of CXCL12. We uncover an unexpected role of the acidic intrinsically disordered region (IDR) in heterocomplex formation and provide the first evidence that the acidic IDR facilitates the ternary HMGB1*CXCL12*CXCR4 interaction on the cell surface. Thus, the interaction of HMGB1 with CXCL12 diverges radically from the classical rigid heterophilic chemokine-chemokine dimerization. Simultaneous interference with the multiple interactions within HMGB1[bullet]CXCL12 complex formation might offer novel pharmacological strategies to inhibit its detrimental activity in inflammatory conditions.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic development of peptide inhibitors targeting the CXCL12/HMGB1 interaction
J. Sgrignani, V. Cecchinato, … A. Cavalli·bioRxiv·Dec 18, 2019
- Oxidation state dependent conformational changes of HMGB1 regulates the formation of the CXCL12/HMGB1 heterocomplex
E. M. A. Fassi, J. Sgrignani, … A. Cavalli·bioRxiv·May 28, 2019
- Discovery of 5,5'-methylenedi-2,3-cresotic acid as a potent inhibitor of the HMGB1/CXCL12 heterocomplex using Virtual Screening and NMR validation
F. De Leo, Q. Giacomo, … G. Musco·bioRxiv·Aug 25, 2020
- Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment
F. De Leo, G. Quilici, … G. Musco·bioRxiv·Mar 1, 2019
- A Potent Nonapeptide Inhibitor for the CXCL12/HMGB1 heterocomplex: A Computational and Experimental Approach
Enrico Mario Alessandro Fassi, Edisa Pirani, … Giovanni Grazioso·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025
- Heterocomplexes between the Atypical Chemokine MIF and the CXC-Motif Chemokine CXCL4L1 Regulate Inflammation and Thrombus Formation
M. Brandhofer, A. Hoffmann, … J. Bernhagen·bioRxiv·Nov 26, 2021